Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Pediatr ; 2007 Aug; 74(8): 790-2
Artículo en Inglés | IMSEAR | ID: sea-82986

RESUMEN

We present two patients with brucellosis concomitant with acute leukemia. Co-existence of acute leukemia with brucellosis which may have similar symptoms, have not been reported earlier. The first case presented with generalized arthralgia, fever, paleness and pancytopenia. The second patient had mild leucopenia and thrombocytopenia. She presented with fever. We carried out the chemotherapy for both ALL and brucellosis simultaneously. While the first patient's fever disappeared within 3 days, the second patient's fever had continued on subfebril level for five days and then disappeared. We achieved the remission in both patients and no reactivation was observed during the follow-up period.


Asunto(s)
Antibacterianos/uso terapéutico , Antineoplásicos/uso terapéutico , Brucelosis/complicaciones , Preescolar , Diagnóstico Diferencial , Femenino , Fiebre , Humanos , Masculino , Pancitopenia/etiología , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones
3.
Indian J Pediatr ; 2006 Jun; 73(6): 531-3
Artículo en Inglés | IMSEAR | ID: sea-83337

RESUMEN

We describe a 5-year-old girl showed recovery of vincristine induced cranial polyneuropathy with pyridoxine and pyridostigmine treatment. A 5-year-old girl was diagnosed preB cell Acute Lymphoblastic Leukemia (ALL). She received chemotherapy according to the previously described modified St. Jude total therapy studies XIII. Five days after the fourth dose of vincristine, she presented with bilateral ptosis. Neurological examination revealed bilateral ptosis, and complete external opthalmoplegia with normal pupillary and corneal reflexes. She received 3.8 mg cumulative dose of vincristin before development of ptosis. A neuroprotective and neuroregenerative treatment attempt with pyridoxine and pyridostigmine was initiated. The bilateral ptosis markedly improved after 7 days of pyridoxine and pyridostigmine treatment and completely resolved after two weeks. The both agents were given for 3 weeks and were well tolerated without any side effects. During the follow up period we did not observe residue or recurrence of the ptosis.


Asunto(s)
Antineoplásicos Fitogénicos/efectos adversos , Blefaroptosis/inducido químicamente , Preescolar , Inhibidores de la Colinesterasa/uso terapéutico , Enfermedades de los Nervios Craneales/inducido químicamente , Femenino , Humanos , Oftalmoplejía/inducido químicamente , Polineuropatías/inducido químicamente , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Bromuro de Piridostigmina/uso terapéutico , Piridoxina/uso terapéutico , Vincristina/efectos adversos , Complejo Vitamínico B/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA